This week, we continue our series of Sg2 Perspectives episodes that dive into the details of health system service lines. In this episode, cardiovascular experts Sg2’s Associate Principal Chad Giese and Director Josh Aaker, PhD, and Vizient’s Associate Principal Doug Beinborn join us to talk CV technologies, including key learnings and challenges organizations should know and be thinking about for electroporation and renal denervation; using artificial intelligence to identify patients at risk for sudden cardiac arrest; and, when it comes to all the hype around new technologies, what should CV programs actually pay attention to?

We are always excited to get ideas and feedback from our listeners. You can reach us at [email protected], find us on Twitter as @Sg2HealthCare, or visit the Sg2 company page on LinkedIn.